دورية أكاديمية
Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month.
| العنوان: | Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month. |
|---|---|
| المؤلفون: | Gantenberg JR; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.; Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA., van Aalst R; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.; Department of Modeling, Epidemiology, and Data Science, Vaccines Medical Affairs, Sanofi, Lyon, France.; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bhuma MR; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA., Limone B; Merative, Cambridge, Massachusetts, USA., Diakun D; Merative, Cambridge, Massachusetts, USA., Smith DM; Merative, Cambridge, Massachusetts, USA., Nelson CB; Vaccines Medical Affairs, Sanofi, Swiftwater, Pennsylvania, USA., Bengtson AM; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Chaves SS; Department of Modeling, Epidemiology, and Data Science, Vaccines Medical Affairs, Sanofi, Lyon, France., La Via WV; Vaccines Medical Affairs, Sanofi, Swiftwater, Pennsylvania, USA., Rizzo C; Vaccines Medical Affairs, Sanofi, Swiftwater, Pennsylvania, USA., Savitz DA; Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA., Zullo AR; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.; Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.; Providence VA Medical Center, Providence, Rhode Island, USA. |
| المصدر: | Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Jun 28; Vol. 13 (6), pp. 317-327. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN: 2048-7207 (Electronic) Linking ISSN: 20487193 NLM ISO Abbreviation: J Pediatric Infect Dis Soc Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Oxford : Oxford University Press |
| مواضيع طبية MeSH: | Respiratory Syncytial Virus Infections*/epidemiology , Respiratory Syncytial Virus Infections*/diagnosis , Seasons* , Hospitalization*/statistics & numerical data, Humans ; United States/epidemiology ; Infant ; Infant, Newborn ; Risk Assessment ; Male ; Female ; Respiratory Syncytial Virus, Human ; Databases, Factual |
| مستخلص: | Background: Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality among US infants. A child's calendar birth month determines their age at first exposure(s) to RSV. We estimated birth month-specific risk of medically attended (MA) RSV lower respiratory tract infection (LRTI) among infants during their first RSV season and first year of life (FYOL). Methods: We analyzed infants born in the USA between July 2016 and February 2020 using three insurance claims databases (two commercial, one Medicaid). We classified infants' first MA RSV LRTI episode by the highest level of care incurred (outpatient, emergency department, or inpatient), employing specific and sensitive diagnostic coding algorithms to define index RSV diagnoses. In our main analysis, we focused on infants' first RSV season. In our secondary analysis, we compared the risk of MA RSV LRTI during infants' first RSV season to that of their FYOL. Results: Infants born from May through September generally had the highest risk of first-season MA RSV LRTI-approximately 6-10% under the specific RSV index diagnosis definition and 16-26% under the sensitive. Infants born between October and December had the highest risk of RSV-related hospitalization during their first season. The proportion of MA RSV LRTI events classified as inpatient ranged from 9% to 54% (specific) and 5% to 33% (sensitive) across birth month and comorbidity group. Through the FYOL, the overall risk of MA RSV LRTI is comparable across birth months within each claims database (6-11% under the specific definition, 17-30% under the sensitive), with additional cases progressing to care at outpatient or ED settings. Conclusions: Our data support recent national recommendations for the use of nirsevimab in the USA. For infants born at the tail end of an RSV season who do not receive nirsevimab, a dose administered prior to the onset of their second RSV season could reduce the incidence of outpatient- and ED-related events. (© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.) |
| References: | MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. (PMID: 37616235) Front Pediatr. 2023 May 05;11:1143735. (PMID: 37215598) Clin Infect Dis. 2017 Sep 15;65(6):1020-1025. (PMID: 28903503) J Infect Dis. 2022 Aug 15;226(Suppl 2):S154-S163. (PMID: 35968878) Lancet Child Adolesc Health. 2020 Nov;4(11):e42-e43. (PMID: 32956616) PLoS One. 2016 Dec 13;11(12):e0168882. (PMID: 27959962) PLoS One. 2016 Nov 29;11(11):e0166226. (PMID: 27898687) Pediatrics. 2014 Aug;134(2):415-20. (PMID: 25070315) MMWR Morb Mortal Wkly Rep. 2023 Apr 07;72(14):355-361. (PMID: 37022977) J Pediatr. 2003 Nov;143(5 Suppl):S127-32. (PMID: 14615711) Pediatr Infect Dis J. 2014 Jun;33(6):e135-40. (PMID: 24445838) J Glob Health. 2020 Dec;10(2):020422. (PMID: 33110581) N Engl J Med. 2023 Dec 28;389(26):2425-2435. (PMID: 38157500) J Infect Dis. 2022 Aug 15;226(Suppl 2):S267-S281. (PMID: 35968871) Epidemiology. 2019 Nov;30(6):918-926. (PMID: 31469696) BMC Infect Dis. 2021 Aug 2;21(1):730. (PMID: 34340679) J Infect Dis. 2022 Aug 15;226(Suppl 2):S184-S194. (PMID: 35968879) J Pediatr. 2000 Dec;137(6):865-70. (PMID: 11113845) Pediatrics. 2013 Aug;132(2):e341-8. (PMID: 23878043) J Infect Dis. 2022 Aug 15;226(Suppl 2):S175-S183. (PMID: 35968868) Vaccines (Basel). 2022 May 06;10(5):. (PMID: 35632484) MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):71-76. (PMID: 29346336) JAMA Netw Open. 2022 Feb 01;5(2):e220527. (PMID: 35226079) PLoS One. 2022 Sep 2;17(9):e0273962. (PMID: 36054117) J Infect Dis. 2022 Aug 15;226(Suppl 2):S282-S292. (PMID: 35968866) N Engl J Med. 2022 Mar 3;386(9):837-846. (PMID: 35235726) J Infect Dis. 2022 Aug 15;226(Suppl 2):S246-S254. (PMID: 35968877) J Infect Dis. 2017 Aug 1;216(3):345-355. (PMID: 28859428) J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):587-595. (PMID: 31868913) Pediatr Pulmonol. 2021 Oct;56(10):3106-3109. (PMID: 34273135) J Infect Dis. 2022 Aug 15;226(Suppl 2):S164-S174. (PMID: 35968869) Pediatr Infect Dis J. 2013 Jun;32(6):e235-41. (PMID: 23385949) Annu Rev Virol. 2020 Sep 29;7(1):83-101. (PMID: 32196426) Epidemiology. 2016 Jan;27(1):91-7. (PMID: 26484424) Obstet Gynecol. 2024 Apr 1;143(4):484-490. (PMID: 38330405) Health Sci Rep. 2018 Oct 12;1(12):e91. (PMID: 30623050) Pediatrics. 2020 Jul;146(1):. (PMID: 32546583) J Perinatol. 2016 Nov;36(11):990-996. (PMID: 27490190) Lancet. 2010 May 1;375(9725):1545-55. (PMID: 20399493) J Infect Dis. 2021 Mar 3;223(5):811-817. (PMID: 33350450) Influenza Other Respir Viruses. 2020 Nov;14(6):630-637. (PMID: 31206246) Euro Surveill. 2024 Jan;29(4):. (PMID: 38275017) Infect Dis Rep. 2022 Jul 24;14(4):558-568. (PMID: 35893478) |
| فهرسة مساهمة: | Keywords: birth month; descriptive epidemiology; infants; lower respiratory tract infection; respiratory syncytial virus |
| تواريخ الأحداث: | Date Created: 20240513 Date Completed: 20240628 Latest Revision: 20240630 |
| رمز التحديث: | 20240630 |
| مُعرف محوري في PubMed: | PMC11212365 |
| DOI: | 10.1093/jpids/piae042 |
| PMID: | 38738450 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!